Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 6/20 | 0.41 |
| ▸ | LMNA | P02545 | 4/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.41 |
| ▸ | DDR2 | Q16832 | 2/20 | 0.37 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | CASP3 | P42574 | 1/20 | 0.35 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.35 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.35 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5277732 | 0.87 | RAB9A (0.50) | TP53LMNAHDAC1HDAC6DDR2 | |
| SCHEMBL5282822 | 0.85 | HDAC1 (0.46) | TP53LMNAHDAC1HDAC6RAB9A | |
| SCHEMBL5290863 | 0.85 | HDAC1 (0.44) | TP53LMNAHDAC1HDAC6GAA | |
| SCHEMBL6038118 | 0.83 | HDAC1 (0.39) | TP53LMNAHDAC1HDAC6DDR2 | |
| SCHEMBL6038370 | 0.82 | TP53 (0.39) | TP53LMNAHDAC1HDAC6DDR2 | |
| SCHEMBL6038003 | 0.81 | TP53 (0.51) | TP53LMNAHDAC1HDAC6POLB | |
| SCHEMBL5282979 | 0.81 | TP53 (0.43) | TP53LMNAHDAC1HDAC6POLB | |
| SCHEMBL5280650 | 0.81 | RAB9A (0.45) | TP53LMNAHDAC1HDAC6RAB9A | |
| SCHEMBL5282375 | 0.79 | AOC3 (0.47) | TP53LMNADDR2MAPK14RAB9A | |
| SCHEMBL5281003 | 0.79 | TP53 (0.68) | TP53LMNAPOLBGAAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060264415-A1 | Inhibitors of histone deacetylase | METHYLGENE INC. | 2006-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060264415-A1 | Inhibitors of histone deacetylase | HDAC1, HDAC3, HDAC11 | TP53 2551/4885LMNA 851/4885HDAC1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.